M. Starck

676 total citations
16 papers, 448 citations indexed

About

M. Starck is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, M. Starck has authored 16 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 5 papers in Molecular Biology and 5 papers in Psychiatry and Mental health. Recurrent topics in M. Starck's work include Multiple Sclerosis Research Studies (10 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (4 papers) and Psychosomatic Disorders and Their Treatments (2 papers). M. Starck is often cited by papers focused on Multiple Sclerosis Research Studies (10 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (4 papers) and Psychosomatic Disorders and Their Treatments (2 papers). M. Starck collaborates with scholars based in Germany, Spain and United States. M. Starck's co-authors include W. Pöllmann, Marianne Dieterich, Andreas Straube, H. Albrecht, Edgar Meinl, Hans von Faber, Lisa Hoffmann, Reinhard Hohlfeld, Markus Krumbholz and Crîngu Antoniu Ionescu and has published in prestigious journals such as Brain, Neurology and International Journal of Molecular Sciences.

In The Last Decade

M. Starck

16 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Starck Germany	8	298	103	99	97	94	16	448
Giordani Rodrigues dos Passos Brazil	9	262 0.9×	79 0.8×	41 0.4×	45 0.5×	167 1.8×	17	377
Tomohiko Uchida Japan	13	289 1.0×	90 0.9×	35 0.4×	93 1.0×	181 1.9×	26	408
Jitesh Rana United States	4	247 0.8×	123 1.2×	82 0.8×	34 0.4×	82 0.9×	10	382
Hanne Roed Denmark	7	208 0.7×	64 0.6×	46 0.5×	23 0.2×	133 1.4×	7	311
Ryohei Ohtani Japan	12	230 0.8×	70 0.7×	37 0.4×	68 0.7×	140 1.5×	28	345
Annalisa Pulizzi Italy	5	285 1.0×	82 0.8×	61 0.6×	32 0.3×	108 1.1×	6	374
Jessica Sagen United States	7	548 1.8×	77 0.7×	50 0.5×	45 0.5×	578 6.1×	13	790
Sam Loveless United Kingdom	8	207 0.7×	178 1.7×	26 0.3×	158 1.6×	81 0.9×	10	406
Patrick Peschl Austria	7	324 1.1×	75 0.7×	36 0.4×	74 0.8×	316 3.4×	10	496
Yanyu Chang China	13	208 0.7×	81 0.8×	16 0.2×	55 0.6×	229 2.4×	42	434

Countries citing papers authored by M. Starck

Since Specialization

Citations

This map shows the geographic impact of M. Starck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Starck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Starck more than expected).

Fields of papers citing papers by M. Starck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Starck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Starck. The network helps show where M. Starck may publish in the future.

Co-authorship network of co-authors of M. Starck

This figure shows the co-authorship network connecting the top 25 collaborators of M. Starck. A scholar is included among the top collaborators of M. Starck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Starck. M. Starck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Starck, M., et al.. (2023). Inner Retinal Layer Changes Reflect Changes in Ambulation Score in Patients with Primary Progressive Multiple Sclerosis. International Journal of Molecular Sciences. 24(16). 12872–12872. 3 indexed citations

Henze, T., Wolfgang Feneberg, Peter Flachenecker, et al.. (2017). Neues zur symptomatischen MS-Therapie: Teil 5 – Fatigue. Der Nervenarzt. 89(4). 446–452. 8 indexed citations

Henze, T., Wolfgang Feneberg, Peter Flachenecker, et al.. (2017). Neues zur symptomatischen MS-Therapie: Teil 4 – Störungen der Sexualfunktion und der Augenbewegungen. Der Nervenarzt. 89(2). 193–197. 2 indexed citations

Henze, T., Wolfgang Feneberg, Peter Flachenecker, et al.. (2017). Neues zur symptomatischen MS-Therapie: Teil 3 – Blasenfunktionsstörungen. Der Nervenarzt. 89(2). 184–192. 6 indexed citations

Henze, T., Wolfgang Feneberg, Peter Flachenecker, et al.. (2017). Neues zur symptomatischen MS-Therapie: Teil 6 – kognitive Störungen und Rehabilitation. Der Nervenarzt. 89(4). 453–459. 4 indexed citations

Henze, T., Wolfgang Feneberg, Peter Flachenecker, et al.. (2017). Neues zur symptomatischen MS‑Therapie: Teil 2 – Gangstörung und Spastik. Der Nervenarzt. 88(12). 1428–1434. 6 indexed citations

Henze, T., Wolfgang Feneberg, Peter Flachenecker, et al.. (2017). Neues zur symptomatischen MS‑Therapie: Teil 1 – Einleitung und methodisches Vorgehen, Ataxie und Tremor. Der Nervenarzt. 88(12). 1421–1427. 5 indexed citations

Starck, M., et al.. (2015). Changing course of Multiple Sclerosis (MS) after stroke: Excessive disease activity in a MS patient after cerebral infarction (P1.122). Neurology. 84(14_supplement). 2 indexed citations

Salmen, Anke, M. Starck, Alexander Winkelmann, et al.. (2014). Lack of efficacy of mitoxantrone in primary progressive Multiple Sclerosis irrespective of pharmacogenetic factors: A multi-center, retrospective analysis. Journal of Neuroimmunology. 278. 277–279. 14 indexed citations

10.

Hemmelmann, Claudia, M. Starck, Uwe K. Zettl, et al.. (2012). Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in Germany. Therapeutic Advances in Neurological Disorders. 5(2). 75–79. 28 indexed citations

11.

Ahsen, Nicolas von, Niels Kruse, Brian E. Huber, et al.. (2009). ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis. Brain. 132(9). 2517–2530. 55 indexed citations

12.

Starck, M., et al.. (2009). Acquired pendular nystagmus in multiple sclerosis: an examiner-blind cross-over treatment study of memantine and gabapentin. Journal of Neurology. 257(3). 322–327. 42 indexed citations

13.

Krumbholz, Markus, Hans von Faber, Lisa Hoffmann, et al.. (2008). Interferon-β increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity. Brain. 131(6). 1455–1463. 140 indexed citations

14.

Hoffmann, Lisa, Markus Krumbholz, Hans von Faber, et al.. (2007). Multiple sclerosis: Relating MxA transcription to anti-interferon-β-neutralizing antibodies. Neurology. 68(12). 958–959. 7 indexed citations

15.

Voltz, Raymond, M. Starck, Vera Carina Zingler, Michael Strupp, & Hans‐Jochem Kolb. (2004). Mitoxantrone therapy in multiple sclerosis and acute leukaemia: a case report out of 644 treated patients. Multiple Sclerosis Journal. 10(4). 472–474. 38 indexed citations

16.

Starck, M., H. Albrecht, W. Pöllmann, Andreas Straube, & Marianne Dieterich. (1996). Drug therapy for acquired pendular nystagmus in multiple sclerosis. Journal of Neurology. 244(1). 9–16. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact